$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

총백추출물의 고지방식이 유도 비만 마우스에서의 항비만 효과 및 근육조직에서의 에너지대사 조절기전 연구
Anti-Obesity Effects and the Regulation of Energy Metabolism in Skeletal Muscle Tissues of Allii Fistulosi Bulbus Extract in High Fat Diet-Induced Obesity Mice 원문보기

한방비만학회지 = Journal of Korean Medicine for Obesity Research, v.22 no.2, 2022년, pp.102 - 114  

최윤용 (동국대학교 한의과대학) ,  이현수 (동국대학교 한의과대학) ,  백수연 (동국대학교 한의과대학) ,  임수민 (동국대학교 한의과대학) ,  정효원 (동국대학교 한의과대학) ,  강석용 (동국대학교 한방신약개발센터) ,  박용기 (동국대학교 한의과대학)

Abstract AI-Helper 아이콘AI-Helper

Objectives: We investigated the effects of Allii Fistulosi Bulbus (AFB) on high fat diet (HFD)-induced obesity in mice and the regulation of energy metabolism in muscle tissues of mice. Methods: The C57BL/6 mice (6 weeks, male) were fed a HFD for 8 weeks and then administrated with AFB extract at 50...

주제어

표/그림 (5)

참고문헌 (53)

  1. Korean Society for the Study of Obesity. Obesity diagnosis [Internet]. Seoul [cited 2022 Oct 17]. Available from: http://general.kosso.or.kr/html/?pmodeobesityDiagnosis. 

  2. Korean Society for the Study of Obesity. Quick reference guideline. Seoul : Korean Society for the Study of Obesity. 2020 : x, 58. 

  3. Korea Iistitute of Oriental Medicine and the Society of Korean Medicine for Obesity Research. Obesity Korean medicine clinical practice guideline. Daejeon : Korea Iistitute of Oriental Medicine and the Society of Korean Medicine for Obesity Research. 2016. 

  4. The Association of Korean Medicine. A variety of treatments [Internet]. 2009 [cited 2002 Oct 17]. Available from: https://www.akom.org/Home/AkomArticleHealth/105320?HealthType3. 

  5. Textbook Compilation Committee of National University of Korean Medicine, Korea. Herbology. Seoul : Younglimsa. 2018 : 174. 

  6. Seo YJ. A study on the gynecologic use of Allii Fistulosi Bulbus in Donguibogam. J Orient Obstet Gynecol. 2011 ; 24(1) : 63-73. 

  7. Terao J, Hiwada M, Taguchi K, Takahara K, Mohri S. Glutathione peroxidase mimics as novel antioxidants from vegetables. Biofactors. 2005 ; 23(1) : 1-6. 

  8. Phaya N, Higashiyamaa T, Tsujib M, Matsuuraa H, Fukushic Y, Yokotaa A, et al. An antifungal compound from roots of Welsh onion. Phytochemistry. 1999 ; 52(2) : 271-4. 

  9. Ueda H, Takeuchi A, Wako T. Activation of immune responses in mice by an oral administration of bunching onion (Allium fistulosum) mucus. Biosci Biotechnol Biochem. 2013 ; 77(9) : 1809-13. 

  10. Chen JH, Chen HI, Wang JS, Tsai SJ, Jen CJ. Effects of Welsh onion extracts on human platelet function in vitro. Life Sci. 2000 ; 66(17) : 1571-9. 

  11. He B, Hao J, Sheng W, Xiang Y, Zhang J, Zhu H, et al. Fistular onion stalk extract exhibits anti-atherosclerotic effects in rats. Exp Ther Med. 2014 ; 8(3) : 785-92. 

  12. Kang MJ, Kim JH, Choi HN, Kim MJ, Han JH, Lee JH, et al. Hypoglycemic effects of Welsh onion in an animal model of diabetes mellitus. Nutr Res Pract. 2010 ; 4(6) : 486-91. 

  13. Shim SB, Ko BS, Ryuk JA, Lee JH, Lee HB, Chan HK, et al. Randomized, double-blind, and placebo-controlled human trial to evaluate the efficacy and safety of Allium Fistulosum L. root extract on improvement of child height growth: study protocol. J Pediatr Korean Med. 2021 ; 35(2) : 11-20. 

  14. Lee CJ, Kim MJ, An SJ. Current treatments on obesity. Korean J Health Promot. 2019 ; 19(4) : 171. 

  15. Korean Society for the Study of Obesity. 2021 obesity fact sheet. Seoul : Korean Society for the Study of Obesity. 2021 : 10-3. 

  16. Apovian CM, Okemah J, O'Neil PM. Body weight considerations in the management of type 2 diabetes. Adv Ther. 2019 ; 36(1) : 44-58. 

  17. Dambha-Miller H, Day AJ, Strelitz J, Irving G, Griffin SJ. Behaviour change, weight loss and remission of type 2 diabetes: a community-based prospective cohort study. Diabet Med. 2020 ; 37(4) : 681-8. 

  18. National Health Insurance Service. Health insurance obesity (E66) medical expenses [serial online]. 2020 [cited 2021 Aug 4]. Available from: https://www.docdocdoc.co.kr/news/articleView.html?idxno2003363. 

  19. Son JW. Recent advances in anti-obesity drugs. J Korean Diabetes. 2022 ; 23(2) : 113-27. 

  20. Garvey WT. New horizons. A new paradigm for treating to target with second-generation obesity medications. J Clin Endocrinol Metab. 2022 ; 107(4) : e1339-47. 

  21. Kuryszko J, Slawuta P, Sapikowski G. Secretory function of adipose tissue. Pol J Vet Sci. 2016 ; 19(2) : 441-6. 

  22. Byun S, Lee CH, Jeong H, Kim H, Kwon HM, Park S, et al. Loss of adipose TET proteins enhances β-adrenergic responses and protects against obesity by epigenetic regulation of β3-AR expression. Proc Natl Acad Sci USA. 2022 ; 119(26) : e2205626119. 

  23. Ferrulli A, Terruzzi I, Senesi P, Succi M, Cannavaro D, Luzi L. Turning the clock forward: new pharmacological and non pharmacological targets for the treatment of obesity. Nutr Metab Cardiovasc Dis. 2022 ; 32(6) : 1320-34. 

  24. Han KS, Lee MJ, Kim HJ. Systematic review on herbal treatment for obesity in adults. J Korean Med Rehabil. 2016 ; 26(4) : 23-35. 

  25. Lim SY. Clinical study of Gambitang for 22 obese patients. J East-West Med. 2011 ; 36(4) : 51-7. 

  26. The Society of Korean Medicine Rehabilitaion. Korean rehabilitation medicine. Seoul : Koonja Publisher. 2005 : 349-59. 

  27. Farrington R, Musgrave IF, Byard RW. Evidence for the efficacy and safety of herbal weight loss preparations. J Integr Med. 2019 ; 17(2) : 87-92. 

  28. Hwang MJ, Shin HD, Song MY. Literature review of herbal medicines on treatment of obesity since 2000 - mainly about Ephedra Herba. J Korean Med Obes Res. 2007 ; 7(1) : 39-54. 

  29. Sohn HY, Kum EJ, Ftyu HY, Jeon SJ, Kim NS, Son KH. Antifungal activity of fistulosides, steroidal saponins, from allium fistulosum L. J Life Sci. 2006 ; 16(2) : 310-4. 

  30. Kim HW, Kim BS, Kim YE, Ko SH. Development of extraction method for Welsh onion root by Alliinase activation. Food Eng Prog. 2015 ; 19(2) : 117-21. 

  31. Tigu AB, Moldovan CS, Toma VA, Farcas AD, Mot AC, Jurj A, et al. Phytochemical analysis and in vitro effects of Allium fistulosum L. and Allium sativum L. extracts on human normal and tumor cell lines: a comparative study. Molecules. 2021 ; 26(3) : 574. 

  32. Shi X, Zhou X, Chu X, Wang J, Xie B, Ge J, et al. Allicin improves metabolism in high-fat diet-induced obese mice by modulating the gut microbiota. Nutrients. 2019 ; 11(12) : 2909. 

  33. Caballero B. Humans against obesity: who will win? Adv Nutr. 2019 ; 10(suppl_1) : S4-S9. 

  34. Choi CS. Review: pathogenesis of insulin resistance. Korean J Med. 2009 ; 77(2) : 171-7. 

  35. Korean Diabetsa Association. Clinical practice guidelines for diabetes. Seoul : Korean Diabetsa Association. 2022 : 11-2, 27-9. 

  36. Kim HG, Han JM. Obesity and pancreatic diseases. Korean J Gastroenterol. 2012 ; 59(1) : 35-9. 

  37. Kusminski CM, Ghaben AL, Morley TS, Samms RJ, Adams AC, An Y, et al. A novel model of diabetic complications: adipocyte mitochondrial dysfunction triggers massive β-cell hyperplasia. Diabetes. 2020 ; 69(3) : 313-30. 

  38. Shim JJ. Secondary causes of fatty liver. Single Topic Symposium. 2018 ; 2 : 16-22. 

  39. Milic S, Lulic D, Stimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014 ; 20(28) : 9330-7. 

  40. Bailey CJ. Metformin: historical overview. Diabetologia. 2017 ; 60(9) : 1566-76. 

  41. Ha JH, Lee SS. Role of AMPK in the regulation of cellular energy metabolism. Endocrinol Metab. 2010 ; 25(1) : 9-17. 

  42. Masarwa R, Brunetti VC, Aloe S, Henderson M, Platt RW, Filion KB. Efficacy and safety of metformin for obesity: a systematic review. Pediatrics. 2021 ; 147(3) : e20201610. 

  43. Maniar K, Moideen A, Bhattacharyya R, Banerjee D. Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: a hypothesis. Med Hypotheses. 2017 ; 104 : 117-20. 

  44. Grandone A, Di Sessa A, Umano GR, Toraldo R, Miraglia Del Giudice E. New treatment modalities for obesity. Best Pract Res Clin Endocrinol Metab. 2018 ; 32(4) : 535-49. 

  45. McCreight LJ, Bailey CJ, Pearson ER. Metformin and the gastrointestinal tract. Diabetologia. 2016 ; 59(3) : 426-35. 

  46. Flory J, Lipska K. Metformin in 2019. JAMA. 2019 ; 321(19) : 1926-7. 

  47. Swiderska E, Strycharz J, Wroblewski A, Szemraj J, Drzewoski J, Sliwinska A. Role of PI3K/AKT pathway in insulin-mediated glucose uptake. In: Szablewski L, editor. Blood glucose levels. London : IntechOpen. 2018 : 37-54. 

  48. Habegger KM, Hoffman NJ, Ridenour CM, Brozinick JT, Elmendorf JS. AMPK enhances insulin-stimulated GLUT4 regulation via lowering membrane cholesterol. Endocrinology. 2012 ; 153(5) : 2130-41. 

  49. Yu BL, Zhao SP, Hu JR. Cholesterol imbalance in adipocytes: a possible mechanism of adipocytes dysfunction in obesity. Obes Rev. 2010 ; 11(8) : 560-7. 

  50. Yuan Y, Cruzat VF, Newsholme P, Cheng J, Chen Y, Lu Y. Regulation of SIRT1 in aging: roles in mitochondrial function and biogenesis. Mech Ageing Dev. 2016 ; 155 : 10-21. 

  51. Wang G, Yu Y, Cai W, Batista TM, Suk S, Noh HL, et al. Muscle-specific insulin receptor overexpression protects mice from diet-induced glucose intolerance but leads to postreceptor insulin resistance. Diabetes. 2020 ; 69(11) : 2294-309. 

  52. Yaspelkis BB 3rd, Kvasha IA, Figueroa TY. High-fat feeding increases insulin receptor and IRS-1 coimmunoprecipitation with SOCS-3, IKKα/β phosphorylation and decreases PI-3 kinase activity in muscle. Am J Physiol Regul Integr Comp Physiol. 2009 ; 296(6) : R1709-15. 

  53. Collino M, Mastrocola R, Nigro D, Chiazza F, Aragno M, D'Antona G, et al. Variability in myosteatosis and insulin resistance induced by high-fat diet in mouse skeletal muscles. Biomed Res Int. 2014 ; 2014 : 569623. 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로